Nice news again... The PPS is not reflacting the latest news anymore. Roche deal, prices for Dr KIM last week and today and a 500,000 dollar buy at market price from insider... breakout comming soon imo. 2014 will be INO year.
you know a stock up 300% in 2 days is more likely in for a drop than INO at this point. I would say take some profit and ride the free shares. Buy INO with your profit. O you are not even in ICLD???
are you scared that it will drop fast? Hope you where in before Friday like me...
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
BLUE BELL, Pa., Nov. 18, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, will be attending Brean Capital's 2013 Life Sciences Summit in New York, and will present at the 25th Annual Piper Jaffray Healthcare Conference in New York and LD Micro's 6th Annual Main Event in Los Angeles.
My guess is there will be more insiders buying soon. INO will open with a little gap and move up all day imo.
eps 1 year ago - 5.82
eps last Q - 0.26
NURO was a profitible company years ago on the edge of becoming a BIG NAME... But some change in payment made them go the other way around. Now 7 years later NURO is back where it was 7 years ago on the edge of becomming a BIG NAME in the diabetes world... On the edge of making huge profits again.
President and Chief Executive Officer of NURO, is scheduled to speak at the Canaccord Genuity Medical Technology & Diagnostics Forum at The Westin Grand Central, New York, NY on November 14, 2013
The next generation of the device, which Gozani said should be out in the first half of 2014, will be even simpler: a third thinner, with some wireless options, including RFID capability. That capability will allow the RFID to “talk” to electrodes, which must be replaced about every two weeks, and will stop the device from trying to stimulate when electrodes need replacing to improve patient comfort and safety. It will also track usage characteristics.
The company also plans to allow the device to send information, such as therapeutic data, to a smartphone, Gozani said.
And, of course, wearables are becoming more of fashion statements than cumbersome medical devices. Gozani said he “wouldn’t go as far as calling (Sensus) a fashion accessory yet, but maybe someday.”
indeed... expecting good run here to + if NURO can hit 6+ i think they will trow the warrants on the market so they will have enouh cash to make it to profibility again. They now have cash till late 2014... it's gonna be a wild year for NURO. up up up imo
Will turn north tomorrow for sure... This will move up till next earnings. Time to get in and load the boat imo. Been out for 7 years now... I didn't wait for nothing. Up up and away.